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ABSTRACT
Background
Gallstone disease is a frequent disorder in the Western world with a prevalence of 10-20%. Recommendations for the assessment and management of gallstones vary internationally. The aim of this systematic review was to assess quality of guideline recommendations for treatment of gallstones.
Methods
PubMed, EMBASE and websites of relevant associations were systematically searched. Guidelines without a critical appraisal of literature were excluded. Quality of guidelines was determined using the AGREE II instrument. Recommendations without consensus or with low level of evidence were considered to define problem areas and clinical research gaps.
Results 
Fourteen guidelines were included. Overall quality of guidelines was low, with a mean score of 57/100 (standard deviation 19). Five of 14 guidelines were considered suitable for use in clinical practice without modifications. Ten recommendations from all included guidelines were based on low level of evidence and subject to controversy. These included major topics, such as definition of symptomatic gallstones, indications for cholecystectomy and intraoperative cholangiography.  
Conclusion
Only five guidelines on gallstones are evidence-based and of a high quality, but even in these controversy exists on important topics. High quality evidence is needed in specific areas before an international guideline can be developed and endorsed worldwide.



INTRODUCTION
Gallstone disease is a common condition with an estimated prevalence of 10-20%, increasing to 15-24% in patients aged over seventy years[1,2]. Most patients with gallstones remain asymptomatic throughout their lifetime, but about 13-22% of patients will eventually become symptomatic[3]. 

Standard treatment of symptomatic gallstone disease is laparoscopic cholecystectomy (LC). Currently, over 700,000 cholecystectomies are performed in the United States each year with health care costs surpassing US$ 6.5 billion[4].  

Various health comparison studies from Europe and the US have shown that the assessment and management of gallbladder and ductal stones varies between surgeons, hospitals and countries[5,6]. A Canadian study demonstrated that patients with similar severity of acute cholecystitis across hospitals in one health care system did not receive comparable care, showing significant practice variation[5]. Rates of cholecystectomy are increasing over the years and geographic variation exists between France, Britain and the US[6].  

A good quality up-to-date internationally endorsed guideline might minimize practice variation through the use of the best available evidence. The Institute of Medicine in the US defines an adequate guideline as ”systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances”[7]. Creating clinically relevant and useful guidelines can be a long and arduous process with all recommendations needing to be supported by high quality evidence. Successful implementation is also critically-dependent on the manner of distribution and promotion of the guideline, active involvement of clinicians, and the need for a mechanism to incorporate feedback and peer review [8,9]. 

Guidelines are important in clinical care, especially in a common problem such as gallbladder and ductal stones. A guideline can provide important direction in all patients with gallstones, regardless of nationality, the hospital or physician. The aim of this study was to conduct a systematic review of available guidelines for the management of patients with gallbladder and ductal stones and to evaluate the quality of evidence.


METHODS
The PRISMA checklist (Preferred Reporting Items for Systematic Reviews and Meta-Analyses[10]) was used to perform this systematic review. 

Literature search
National and international guidelines on gallbladder and ductal stones were identified by a systemic search of PubMed, EMBASE and the Cochrane library in
October 2015. We used the following search terms for Medline: laparoscopic cholecystectomy, cholecystolithiasis, gallstones, choledocholithiasis, ductal stones, biliary tract surgical procedures, guideline, consensus development conference.  The EMBASE database and the Cochrane Library were searched with similar terms. The full search is described in detail in appendix 1. Websites of all international Gastroenterological and Surgical Associations were searched for additional relevant guidelines.  

Eligibility criteria
Guidelines were eligible for inclusion when the following inclusion criteria were met; (a) description of assessment and/or management of a topic associated with gallbladder or ductal stones; (b) full text available; (c) critical appraisal of the used literature. The most recent version of each guideline was used. No limits regarding language or design of the guideline were defined. Biliary and pancreatic malignancies, gallbladder polyps, gallbladder dyskinesia, cholecystitis, cholangitis and pancreatitis were outside the scope of this review. 

Selection of suitable guidelines and data extraction
After removal of duplicates all available articles were reviewed for relevance by screening the title and abstract. The eligibility criteria were assessed in the full-text guidelines. Two authors (AhvD, PRdR) were involved in data extraction and checking the data for accuracy, which was done using a pre-defined pro forma. The data fields in the template included title, organisation, group of authors, year of publication, development, multidisciplinary character, the use of figures and flowcharts, the rating systems used, the use of peer review, mode of distribution and all recommendations. 

Comparison of guidelines and recommendation assessment
In order to make comparison of the guidelines possible, every individual critical appraisal of the literature was converted to levels of evidence (LoE), in line with the system devised by the Oxford Centre for Evidence-based Medicine, version 2011[11] (see appendix 2). Recommendations were arranged according to the GRADE approach [12] (see appendix 2) and were further organised depending on the consensus assigned in the guideline. 

If a recommendation was given in two or more guidelines, and the authors of the original guideline agreed on the recommendation, it was classified as a ‘consensus’. Where only one guideline described the recommendation or the authors did not agree on the recommendation, it was ranked as ‘no consensus’.  Only recommendations without consensus or with a low level of evidence were selected for further discussion if they were contentious or debatable issues in clinical practice. 

Quality assessment of included guidelines
The Appraisal of Guidelines for Research and Evaluation Instrument (AGREE II) was used to assess the quality of the included guidelines [13] by both reviewers (AhvD, PRdR). This instrument uses 23 key items organized in six domains with each item rated on a 7-point Likert scale. A scaled domain score was calculated per domain and was then displayed as a percentage with a maximum of 100%. An overall assessment was then assigned regarding the quality of the guideline and recommended use of the guideline. An overall score of 50 or less is considered low quality and the guideline is not considered suitable for clinical practice. A score of 50 to 69 is considered moderate quality and the guideline can only be advised for clinical practice after considerable modifications. A score of 70 or higher represents a high quality guideline that is appropriate for use in clinical situations.



RESULTS
Literature search 
The systematic search (October 2015) identified 4270 articles (figure 1). Removal of duplicates and screening of the title and abstract resulted in 111 remaining articles. Further refinement of full texts retrieved 21 possible guidelines. Eleven additional guidelines were found by searching the websites of relevant associations and cross-referencing. 

Excluded and included guidelines   
After careful assessment of a total of 33 possible guidelines, 19 were excluded, due to a lack of a critical appraisal of the literature used (n=12), duplication (n=5) or absence of a full text version (n=2) (see table 1 and appendix 3). Only the most recent version of the guideline was included in this review. Of four of the included guidelines retrieved by the search, an earlier version was excluded (as indicated in appendix 3). 
Guideline content was developed by a committee or a writing group as a result of a consensus development conference or by an expert panel, as shown in table 2. Fourteen guidelines were included in the present review, in English, German and Dutch (table 2). Nine guidelines covered all aspects of gallbladder and ductal stones [14–22]. One guideline specifically commented on the prevention and treatment of bile duct injuries [23] and the remaining four focussed on the diagnosis and management of choledocholithiasis [24–27]. 
Eleven guidelines were developed by a multidisciplinary team; nine use flowcharts or algorithms. The guidelines used various rating systems for grading the quality of the evidence, including instruments developed by guideline authors. Most guidelines were peer-reviewed and distributed by either a publication in a journal or on a website.  

Guideline recommendations with consensus (table 3)
High level of evidence consensus was reached for sixteen recommendations. The use of ursodeoxycholic acid in selected patients, safety of LC in patients with liver cirrhosis Child’s Pugh A/B, the use of prophylactic antibiotics in LC, the routine use of a drain in LC and evidence on the SILC procedure (single incision LC) and the three-port technique all gained evidence level 1 and are therefore of the highest quality. 


Guideline recommendations without consensus
Ten recommendations where no consensus was reached or where only a low level of evidence exists are further discussed (table 4).

1. Definition of uncomplicated symptomatic gallstone disease 
Biliary colic is usually described as the typical presentation of a patient with symptomatic gallstone disease. As defined by the Rome criteria, this is a steady pain, located in the epigastrium and/ or right upper quadrant, and lasting at least 30 minutes [28]. However, only three out of the 13 guidelines offer a description of ‘typical biliary symptoms’, and these descriptions are different. The Dutch ‘gallstones’ guideline (DAS, by the Dutch Association of Surgery)[29] describes two other symptoms that, in addition to biliary colic, can be associated with gallstone disease: pain radiating to the back and a positive response to a simple analgesic (LoE 2). The S3 Guidelines for Diagnosis and treatment of Gallstones (S3, by the German Society for Digestive and Metabolic Diseases)[15] is in agreement with this definition, but adds that symptomatic gallstone disease is often associated with nausea and vomiting (LoE 4). In contrast, the guideline ‘Management of Gallstones’ (AAFP1, by the American Academy of Family Physicians)[17] defines typical biliary pain as ‘a steady pain which rapidly increases in intensity and reaches a plateau, can last for four to six hours and sometimes radiates to the right upper back’ (LoE 4). 

2. Laboratory tests 
Four guidelines discuss the use of laboratory tests in the preoperative screening of LC[15,19,20,29]. DAS[29] state that laboratory tests is not useful in the assessment of symptomatic gallstone disease (LoE 5), whereas S3[15] considers liver function tests, a full blood count and blood coagulation tests mandatory (LoE 5). The guideline ‘Gallstone disease; Diagnosis and management of cholelithiasis, cholecystitis and choledocholithiasis’ (NICE, by the National Institute of Health and Care Excellence)[19] is in agreement that there is ‘sufficient evidence’ to advise the use of liver function tests to assist with identification of common bile duct stones (CBDS) (LoE 4)[19]. According to UMH, the guideline made by the University of Michigan Health System (Evaluation and Management of Gallstone-Related Diseases in Non-Pregnant Adults) the evaluation of gallstones routinely includes laboratory tests (LoE4)[20]. 
3. Contraindications for LC
The guidelines for the clinical application of laparoscopic biliary tract surgery (SAGES, by the Society of American Gastrointestinal Endoscopic Surgeons)[16] is the only guideline to describe ‘relative’ contra-indications for LC and these include untreated coagulopathy, lack of surgical expertise or equipment, high chance of laparoscopic failure, advanced cirrhosis or liver disease and suspected malignancy of the gallbladder (LoE 4). 

4. The use of the Critical View of Safety during LC
The Critical View of Safety is a method used during laparoscopic cholecystectomy to help identify the biliary anatomy and was first described by Strasberg [30]. The use of the Critical View of Safety is mentioned in four guidelines ([16,23,31,32]). All guidelines are in agreement that optimal exposure of the relevant anatomy is essential for a safe laparoscopic procedure (LoE 2). Specifically, the guideline ‘Laparoscopic cholecystectomy: consensus conference-based guidelines’ (EAES/ISS, by the Italian Surgical Societies Working Group) [21] recommends use of the Critical View of Safety, but with a footnote that there is limited evidence to support this approach (LoE 4).   

5. The use of IOC during LC
Four guidelines discuss the use of IOC during cholecystectomy [16,21,23,29]. The rationale for performing routine IOC is to identify choledocholithiasis and to clarify the biliary anatomy.  In the absence of data about long-term complications in patients who do not undergo IOC, SAGES, DAS and EASL [21,22,29] suggest that routine use of IOC cannot be recommended (LoE3). In relation to this, a systematic review conducted by Ford et al[33] concluded that the available evidence is of low to moderate quality only and that no benefit of IOC has been shown.
The selective use of IOC to help prevent BDI is a controversial topic. DAS, EAES, EASL and SAGES [16,22,23,29] state that IOC may decrease the risk of BDI (LoE 3-4). EAES/ISS [21] suggests that selective use of IOC can be useful, as it allows for therapeutic intervention and, consequently may reduce the risk of BDI (LoE 3-4). If BDI does occur, GS [29] suggests that IOC can identify this complication in 80% of cases (LoE 4). Furthermore, EAES [23] states that, if used correctly, IOC can provide early identification of a BDI (LoE 3). 
6. Subtotal cholecystectomy 
Subtotal or partial cholecystectomy is practised by some as an alternative to conversion during a difficult dissection. Subtotal cholecystectomy is mentioned only in one guideline[21], where it is described as an option when the biliary anatomy is unclear (LoE 2). They do advise that closure of either the remnant of the gallbladder or the cystic duct (or both) ‘seems favourable, without any definitive conclusion’, to prevent bile leaks and reduce the need for postoperative ERC (endoscopic retrograde cholangiography). 

7. Gallstone spillage and lost stones during LC
Three guidelines address iatrogenic gallbladder perforation during LC [21,22,29]. Overall, the reported incidence of lost stones is between 5 and 20% (LoE 3). EAES/ISS [21] advises retrieval of as many spilt stones as possible, particularly when they are larger than 15 mm, when there is a large number of stones, and whenever there are spilt pigment stones[34] (LoE 2). The type of stone seems to be a relevant in retrieving stones, as bacterial contamination is present in 83% of black, brown or mixed stones but only in 33% of cholesterol stones[35]. These authors also conclude that routine use of antibiotics following spillage of stones or bile is not necessary. DAS advises against an extensive search for intraperitoneal lost stones[29] (LoE 4). EASL comments that the intra-operative loss of gallstones is not a reason for conversion to an open procedure, but that ‘every attempt’ should be made to retrieve lost stones by lavage[22] (LoE 5). 

8. Persistent symptoms following LC
The occurrence of persistent symptoms following LC is only described in three guidelines ([15,22,29]). DAS and EASL[22,29] comment that up to 40% percent of patients complain of persistent symptoms postoperatively, and consequently recommend to  correctly and fully inform all patients about this possibility preoperatively (LoE 5). EASL goes on to advise endoscopic ultrasound or MRCP (magnetic resonance cholangiopancreatography) in patients with persistent symptoms (LoE4-5). S3[15] states that about 30% of patients will have lasting symptoms postoperatively (LoE 4). 

9. Management of common bile duct stones
According to the British Society of Gastroenterology (Guidelines on the management of common bile duct stones, BSG), S3, EASL and DAS [15,22,25,29], the treatment for ductal stones can be either ERC with sphincterotomy followed by stone extraction using a basket or balloon catheter or LC combined with laparoscopic common bile duct exploration (if the necessary surgical expertise is available), as they are comparable in morbidity and mortality (LoE 1). DAS adds that experience in exploration of the common bile duct is declining fast, so it is now associated with an increase in morbidity. Therefore, they advise ERC with sphincterotomy and stone extraction as the first choice in the treatment of ductal stones in the Netherlands (LoE 3).  
NICE recommends ‘bile duct clearance‘ (surgical or with ERC) and LC in patients with both symptomatic and asymptomatic ductal stones (LoE4-5). EAES/ISS, BSG and S3 [15,21,25] also recommend balloon dilatation of the papilla as an alternative in patients with a high risk of bleeding after sphincterotomy (e.g. coagulopathy or cirrhosis, LoE 2).

10. Timing of LC in patients with ductal and concomitant gallbladder stones. 
According to GMC, GDD and CDL[19,21,25], cholecystectomy is recommended for all patients with ductal stones and concomitant symptomatic gallbladder stones (LoE 4). DAS, NICE, EAES/ISS and S3 [15,19,29] suggest that when ERC and sphincterotomy  are performed following LC, this should not be on the same day (LoE 4).  
S3 advises removal of the gallbladder within six weeks of ERC and stone removal (LoE 2). In contrast, the guideline of the Philippine Society of general surgeons (Evidence-based Clinical practice Guidelines on Bile Duct Stones, PSGS) [27] recommends  cholecystectomy within 24-48 hours of clearance of the bile duct (LoE 2-3), while ASGE2[26] suggests that cholecystectomy should be performed within 2 weeks of ERC (LoE 4). DAS and EASL advise LC within 72 hours after sphincterotomy[22,29]. They base this on the randomized trial by Reinders et al that showed that LC within 72 hours leads to significantly less recurrent biliary events (2.1% vs 36.2%) when compared to LC following 6-8 weeks[36]. There was no difference in the number of conversions or operating time. NICE found little evidence and did not feel ‘confident’ to make a specific recommendation[19]. 


Quality assessment of the included guidelines
The appraisal of individual guidelines is shown in appendix 4. Five of the guidelines reached an overall quality assessment of 70 or more (out of 100) and, being high quality, are recommended for use in clinical practice[15,19,21,22,29]. Five guidelines received a total overall score between 50 and 70 and were in need of considerable modifications before recommending their clinical use. Four other guidelines were not considered suitable for use in clinical situations due to an overall assessment of only 50 or less. 
Mean scores for each domain and the overall score were calculated (appendix 4). The domain ‘applicability’ reached the lowest score of 37 (out of a 100, with an SD of 17).  This domain handles the implementation strategy of the guideline. The total overall mean score of the guidelines was 57 (out of a 100, SD 19). 


DISCUSSION

This systematic review is the first to assess the evidence and quality of guidelines on gallstone disease. Thirteen guidelines were included after a systematic search of the literature and relevant websites. Ten topics with a low level of evidence or where there was lack of consensus were also identified for further discussion. 

The development of guidelines has increased gradually over recent decades as a result of the rising demand for evidence-based practice. Ideally, guidelines should incorporate the best available and most recent evidence, which should be assessed and rated with reliable and validated instruments. Perceived benefits of a well-developed guideline include improved efficiency, a reduction of inappropriate care and lower overall healthcare costs[37]. Unquestionably, guidelines are effective in improving patient care when they are appropriately conceived, developed, distributed and implemented[38,39].  
This review showed that only 33 guidelines exist worldwide, which is surprising considering that gallstones are such a common clinical problem. Furthermore, 19 of these guidelines had to be excluded, mostly due to lack of a critical appraisal of the relevant literature. Also, only eight out of the 14 guidelines selected for review were developed or updated in the last five years. 

The 14 guidelines analyzed were of low to moderate quality only, with a mean overall score of 57 (out of a 100, SD 19). Ultimately, only five were deemed to be of high enough quality to be used in clinical practice. Interestingly, they originated from Germany, The Netherlands and the United Kingdom, arguably representing the views of only one part of the world. 

Six out of 14 included guidelines were in need of considerable modifications to be implemented in clinical practice. As ‘applicability’ was the domain that had the lowest mean score in the AGREE II assessment, this is one of the areas that needs more attention in the development of guidelines. ‘Applicability’ pertains mostly to the implementation and dissemination of the guideline. Failure to translate research into daily clinical practice is a well-known problem with clinical guidelines. In general, up to 40% of patients never receive evidence based treatment despite the availability of a clinical evidence based guideline [40]. This suggests that correct implementation and dissemination of information is just as important as accurate content and development of the guideline. Also, measuring the long-term impact of a guideline on mainstream clinical practice remains problematic, but is important when considering updates or modifications of the guideline. Not only are guidelines important in clinical practice, in medico-legal cases they are often used to assess if the doctor under scrutiny has followed the right policy. In these situations, it could have serious consequences when guidelines are not reliable.    

Ten recommendations were identified where there was no consensus or where there was only limited evidence to support the recommendations. Interestingly, one of these relates to the definition of ‘uncomplicated symptomatic gallstone disease’. Lack of a worldwide consensus of this definition may be the biggest impediment to establishing guidelines for managing this condition. The first issue a new and improved guideline must assess is what constitutes ‘typical biliary symptoms’ and ‘atypical biliary symptoms’, as the rest of the guideline is based solely on this definition. The current definition of the ‘Rome criteria’ is clearly not effective, as 30-40% of patients still suffer from symptoms after cholecystectomy.

Other important recommendations with no consensus or only limited evidence include the value of the CVS during surgery, the role of preoperative laboratory tests, absolute and relative contraindications for cholecystectomy, the role of partial cholecystectomy, and performance of an IOC during LC. The lack of consensus on these subjects between guidelines is most likely due to lack of high-quality evidence. In these situations, it is impossible for a guideline committee to form an evidence-based recommendation on that topic and the recommendation will be based on expert opinion.  It is notable, that daily practice in such a common disease as gallstones is mostly based on habits and historical principles. More research is certainly needed in certain topics and large numbers of patients may be needed to settle some of the recommendations with low quality of evidence.

Guidelines in other areas of medicine suffer from the same problem. Several reviews of guidelines have been published in the last 5 years. Most of the authors conclude that guideline committees need to improve their methodology to create evidence-based guidelines that concur on major topics[41–44]. Apparently, the varying quality of guidelines is a worldwide problem and not specific to one medical specialty. 
This systematic review has several limitations. Firstly, there is a selection bias in the included reviews, since not all guidelines are published or placed online. Secondly, the evidence as used in the included guidelines was only categorized, but a systematic review of the selected recommendations was not performed. Consequently, this review is not representative of all current available evidence. 
Also, for this review all available guidelines were included, regardless of their publication date. There is a certain bias in comparing older and newer guidelines, as newer guidelines could incorporate more recent evidence and as such may differ in recommendation when compared to the older guideline. 

In conclusion, this study has highlighted significant deficiencies in the evidencebase of gallstone disease and as a result most guidelines are associated with a low level of evidence and lack consensus. Focused high quality research is needed to definitively address the knowledge gaps in the diagnosis and management of gallstone disease.. Ultimately, when focused research is completed updated guidelines should be developed by an international, multidisciplinary team, and then well implemented with endorsement by a wide range of international medical and surgical societies. This will contribute to a decrease in practice variation and improve patient care.  
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Tables and figures

Figure 1. Flowchart of inclusion of guidelines (search 14-10-2015)



Table 1. Included guidelines, ranked by year of publication
Organisation	Guideline	Abbreviation	Year	Language
European Association for the Study of the Liver	EASL Clinical Practice Guidelines on the Prevention, Diagnosis and Treatment ofGallstones[22]	EASL	2016	English
Dutch Association of Surgery	Gallstone [29]	DAS	2016	Dutch
European Association of Endoscopic Surgery and Italian Surgical Societies Working Group	Laparoscopic cholecystectomy: consensus conference-based guidelines[21]	EAES/ISS	1994, reviewed2015	English
American Academy of Family Physicians	Surgical and Nonsurgical Management of Gallstones [18]	AAFP2	2014	English
National Institute of Health and Care Excellence	Gallstone disease; Diagnosis and management of cholelithiasis, cholecystitis and choledocholithiasis[19]	NICE	2014	English
University of Michigan Health System	Evaluation and Management of Gallstone-Related Diseases in Non-Pregnant Adults[20]	UMH	2014	English
European Association of Endoscopic Surgery 	Prevention and treatment of bile duct injuries during laparoscopic cholecystectomy [23]	EAES	2012	English
American Society for Gastrointestinal Endoscopy	The role of endoscopy in the management of choledocholithiasis [26]	ASGE2	2011	English
Society of American Gastrointestinal Endoscopic Surgeons	Guidelines for the clinical application of laparoscopic biliary tract surgery [16]	SAGES	1990, reviewed2010	English
American Society for Gastrointestinal Endoscopy	The role of endoscopy in the evaluation of suspected choledocholithiasis [24]	ASGE1	2010	English
British Society of Gastroenterology	Guidelines on the management of common bile duct stones [25]	BSG	2008	English
German Society for Digestive and Metabolic Diseases / German Society for the Surgery of the Alimentary tract	S3 Guidelines for Diagnosis and treatment of Gallstones [15]	S3	2007	German
American Academy of Family Physicians	Management of Gallstones [17]	AAFP1	2005	English
Philippine society of general surgeons 	Evidence-based Clinical practice Guidelines on Bile Duct Stones [27]	PSGS	2005	English





Table 2. Content of included guidelines
Guideline	Development 	MD	Use of flowchart/algorithm	Rating quality of evidence	References	Peer review	Distribution
AAFP1	Expert panel	No	No	SORT	29	No	Published in PRJ 
PSGS	Expert panel and committee	No	No	Oxford	19	Yes	Published on website, presented on national conference
DAS	Committee	Yes	Yes, one	Own	Not numbered separately	Yes	Published on website, presented on national conference
S3	Committee 	Yes	Yes, one	Own	591	Yes	Published on website and in PRJ and presented in educational meetings
BSG	Writing group	Yes	Yes, two	North of England evidence-based guideline project	247	Yes	Published in PRJ and on website
SAGES	Committee	Yes	No	Own	177	Yes	Published in PRJ and on website
ASGE1	Committee 	Yes	Yes, one	GRADE	106	Yes	Published in PRJ and on website
EAES	Expert panel	Yes	Yes, two	Oxford	695	Yes	Published on website and in PRJ, presented on national conference
ASGE2	Committee	Yes	No	GRADE	224	Yes	Published in PRJ and on website
EAES/ISS	Consensus development conferences and committee	Yes	Yes, one	GRADE	300	Yes	Published online and published in PRJ
AAFP2	Expert panel	Yes	Yes, one	SORT	52	No	Published in PRJ
NICE	Guideline development group	Yes	Yes, two	GRADE	Not numbered separately	Yes	Published on website and in PRJ
UMH	Guideline development team	Yes	Yes, two	Own	25	Yes	Published online 
EASL	Guideline Panel 	Yes	No	GRADE	675	Yes	Published online and on website

MD; developed by a multidisciplinary team, References; Total number of references used, SORT; Strength of Recommendation Taxonomy (a system of grading evidence)[63], PRJ; Peer reviewed journal, Oxford; Oxford Centre for Evidence-based Medicine Levels of Evidence[11], GRADE; GRADE system for rating the quality of evidence [64]

















Recommendation  	Guideline	LoE/ grade 
Expectant treatment is justified in patients with asymptomatic gallstone disease.	S3, EAES/ISS, AAFP1, DAS, AAFP2, NICE, EASL	LoE 2 / moderate
Transabdominal ultrasound is the diagnostic tool of choice for symptomatic gallstone disease.	S3, AAFP1, DAS, AAFP2, NICE, UMH, EASL	LoE 2 / moderate
Oral dissolution therapy is only recommended for selected patients.	S3, AAFP1	LoE 1 / high
Ursodeoxycholic acid can be used as a prevention in high risk patients. 	S3, DAS, EASL	LoE 2 / moderate
Shock wave lithotripsy is not recommended for gallbladder stones	S3, EASL	LoE 3/ moderate
The treatment of cholecystolithiasis in pregnancy is the same as in non-pregnant patients.	S3, EAES/ISS, DAS, AAFP2, EASL	LoE 2 / moderate
LC is a safe procedure in patients with Child’s Pugh A or B	SAGES, EAES/ISS, EASL	LoE 1 / high
Prophylactic antibiotics in routine, elective LC are not necessary.	SAGES, AAFP2, EASL	LoE 1 / high
Routine use of a drain is not necessary after elective LC.	SAGES, EAES/ISS, DAS	LoE 1 / high
SILC has no proven advantages over LC. 	SAGES, EAES/ISS	LoE 1 / high
The three-port technique is similar to the traditional four port technique.	SAGES, EAES/ISS, EAES	LoE 1 / high
LC in day surgery is safe in carefully selected patients.	EAES/ISS, NICE, SAGES, S3, DAS, EASL	LoE 2 / moderate
In patients with a low probability of CBDS no further evaluation is necessary.	ASGE1, DAS, UMH	LoE 2-3 / moderate
In patients with suspected CBDS initial evaluation should consist of serum liver tests and a transabdominal ultrasound	S3, ASGE1, BSG, DAS, EASL	LoE 1-3 / moderate
Following ultrasound, MRC or EUS can be used, depended on availability and experience.	ASGE1, DAS, NICE, EASL	LoE 3 / moderate
ERC is not used solely as a diagnostic test, due to the associated complications.	SAGES, EAES/ISS, DAS	LoE 2 / moderate
LC combined with LCBDE has a comparable mortality and morbidity with ERC followed by LC. 	SAGES, EAES/ISS, AAFP1, BSG, DAS	LoE 1 / high
Table 3. Recommendations from included guidelines, with consensus and high to moderate level of evidence 
 

LoE; Level of Evidence, LC; laparoscopic cholecystectomy, SILC; single incision laparoscopy, CBDS; common bile duct stones, MRC; magnetic resonance cholangiography, EUS; endoscopic ultrasonography, ERC; endoscopic retrograde cholangiography, LCBDE; laparoscopic bile duct exploration




Table 4. Recommendations from included guidelines, without consensus or with a low level of evidence
Subject	Reason for discussion	Guideline	LoE / grade 	Consensus
The definition of symptomatic gallstone disease	Ranges from a ‘steady increasing pain, which can last for 6 hours’ to ‘pain, lasting at least 30 minutes’ 	S3, AAFP1, DAS, EASL	LoE 4-5 / low-very low	No
The use of laboratory tests in preoperative assessment before LC	Some guidelines advise routinely performing laboratory tests, and other find them not useful	S3, DAS, NICE, UMH, EASL	LoE 5 / very low	No
Contraindications for LC 	Are only described in one guideline as ‘untreated coagulopathy, lack of surgical expertise or equipment, high chance of laparoscopic failure, advanced cirrhosis or liver disease and suspected malignancy’	SAGES	LoE 4 / low	No
The use of CVS during LC	Limited evidence is available to recommend the use of the CVS in LC to prevent BDI	SAGES, EAES/ISS, EAES, DAS	LoE 4/ low	Yes
The use of IOC during LC 	Little evidence exists to either recommend or discourage the routine or selective use of IOC during LC	SAGES, EAES/ISS, EAES, DAS, EASL	LoE 3-4 / low	Yes
Subtotal cholecystectomy during LC 	There is no consensus on the role of subtotal cholecystectomy as an alternative during LC 	EAES/ISS	LoE 2 / moderate	No
Lost stones and gall spill during LC 	One guideline recommends a search for as much spilt gallstones as possible, while the other advises against an extensive search	EAES/ISS, DAS, EASL	LoE 2-5 / moderate-low	No
Persistent symptoms following LC	About 30-40 percent of patients seem to have persistent symptom after LC, but the quality of the evidence is low 	S3, DAS, EASL	LoE 4-5 / low-very low	Yes
The standard treatment of CBDS	Some guidelines advise either ERC with sphincterotomy with stone extraction or LC with LCBDE and other guidelines have a preference for one of the techniques	S3, BSG, DAS, EASL	LoE 1 / high	No
Timing of LC in patients with CBDS and concomitant symptomatic gallstones following ERC	Timing of cholecystectomy after ERC varies from 24-72 hours to within two weeks. 	S3, PSGS, ASGE2, DAS, NICE, EASL	LoE 4 / low	No
LC; laparoscopic cholecystectomy, CVS; critical view of safety, BDI; bile duct injury, IOC; intra-operative cholangiography, CBDS; common bile duct stones, ERC; endoscopic retrograde cholangiography, LCBDE; laparoscopic bile duct exploration




APPENDIX

Appendix 1. Search strategy 

For every keyword (MeSH for Medline and EMTREE for EMBASE) the matching textwords were searched as well, but are not named below for clarity. 

Medline, 14-10-2015, 1516 hits 
1. 	"cholecystectomy, laparoscopic"[MeSH Terms] OR "Cholecystectomy"[Mesh] OR cholecyst*
2. 	"gallstones"[MeSH Terms] OR "cholecystolithiasis"[MeSH Terms] 
3. 	"biliary tract"[MeSH Terms] OR "Biliary Tract Surgical Procedures"[Mesh] OR      "Biliary Tract Diseases"[Mesh] OR "Gallbladder"[Mesh] OR  "Gallbladder Diseases"[Mesh]
4.  	"Guideline" [Publication Type] OR "Guidelines as Topic"[Mesh] OR "Practice Guideline" [Publication Type] OR "Guideline Adherence"[Mesh] OR guideline* OR "guideline"[All Fields]
5.  	"Consensus"[Mesh] OR "Consensus Development Conference, NIH" [Publication Type] OR "Consensus Development Conference" [Publication Type] OR "Consensus Development Conferences, NIH as Topic"[Mesh] OR "Consensus Development Conferences as Topic"[Mesh] OR consensus* OR  "consensus"[All Fields]
6. 	1 OR 2 Or 3
7. 	4 OR 5
8. 	6 AND 7

EMBASE, 14-10-2015, 2725 hits
1.	laparoscopic cholecystectomy.mp. or exp cholecystectomy/
2.	cholecystolithiasis.mp. or cholelithiasis.mp. or gallstones.mp. or gallstone.mp. 
3.	exp gallbladder/ or exp cholecystitis/ or galbladder diseases.mp. 
4.	biliary tract.mp. or biliary tract surgery.mp. 
5.	guideline.mp. or exp practice guideline/
6.	exp consensus development/ or exp consensus/ or consensus.mp.
7.	practice parameter.mp. or (consensus or guideline*).mp.
8.	1 or 2 or 3 or 4
9.	5 or 6 or 7
10.	8 and 9

Cochrane library, 14-10-2015, 29 hits
1.	Cholecystectomy
2.	Gallstone
3.	Guideline 
4.	1 or 2
5.	4 AND 3 




Appendix 2. Levels of evidence (adapted from the OCEBM Levels of Evidence [11] and GRADE [12]) 

Level of Evidence (LoE)	Subject of article: Diagnosis	Subject of article: Treatment	GRADE
LoE 1	Systematic review of good quality cross-sectional studies	Systematic review of randomized trials 	High-Moderate
LoE 2	Individual good quality cross sectional studies	Randomized trial or observational study 	Moderate
LoE 3	Non-consecutive studies 	Non-randomized controlled cohort / follow-up study 	Moderate-Low
LoE 4	Case-control studies	Case series, case-control studies or poor quality prognostic cohort	Low-Very low
LoE 5	Mechanism-based reasoning	Mechanism-based reasoning	Very low


Appendix 3. Details of excluded guidelines

No.	Organisation	Guideline	Reason for exclusion
1	National Institute of Health 	Consensus Development Conference Statement: Gallstones and Laparoscopic Cholecystectomy [45]	No critical appraisal of literature
2	National Institute of Health	Gallstones and laparoscopic cholecystectomy [46]	No critical appraisal of literature
3	Society of American Gastrointestinal Endoscopic Surgeons	The role of laparoscopic cholecystectomy [47]	No critical appraisal of literature
4	American College of Physicians 	Guidelines for the treatment of Gallstones [48]	No critical appraisal of literature
5	Association of Laparoscopic Surgeons	The gallbladder and bile ducts [49]	No critical appraisal of literature
6	Malaysian Society of Gastroenterology & Hepatology	Consensus on Management of Gallstone Disease [50]	No critical appraisal of literature
7	European Association of Endoscopic Surgery 	Diagnosis and treatment of common bile duct stones (CBDS) [51]	No critical appraisal of literature
8	Japan Biliary Association	Evidence-based guideline for the treatment of gallstones [52]	No full text available
9	World Gastroenterology Organisation	Asymptomatic gallstone disease [53]	No critical appraisal of literature
10	Society for Surgery of the Alimentary tract 	Treatment of Gallstone and Gallbladder Disease [54]	No critical appraisal of literature
11	National Institute for Health and Clinical Excellence	Single-incision laparoscopic cholecystectomy [55]	No critical appraisal of literature
12	Russian Scientific Society of Gastroenterologists	Guidelines in the diagnosis and treatment of cholelithiasis [56]	Full text not available
13	Department of Health, Government of Western Australia	Diagnostic Imaging Pathways: Laparoscopic Cholecystectomy [57]	Unknown grading of literature
14	Society for Surgery of the Alimentary Tract	Evidence-based Current Surgical Practice: Calculous Gallbladder Disease[58]	No critical appraisal of literature
15	Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland	Commissioning Guide for Gallstone Disease [59]	No critical appraisal of literature
16 and 17	Society of American Gastrointestinal Endoscopic Surgeons	The role of laparoscopic cholecystectomy. Guidelines for clinical application. Society of American Gastrointestinal Endoscopic Surgeons (SAGES)[47]	Earlier version of included guideline
18	Society of American Gastrointestinal Endoscopic Surgeons	Guidelines for the clinical application of laparoscopic biliary tract surgery (1994[60] and 2000[61])	Earlier version of included guideline
19	European Association of Endoscopic Surgery	The E.A.E.S. Consensus Development Conferences on laparoscopic cholecystectomy,appendectomy,  and hernia repair. Consensus statements[62]	Earlier version of included guideline
20	Dutch Association of Surgery	Gallstone[32]	Earlier version of included guideline







Appendix 4.  Scores per domain (in per cent) and overall assessment according to the AGREE II instrument

Guideline	Scope and purpose	Stakeholder involvement	Rigour of development	Clarity of presentation	Applicability	Editorial independence	Overall assessment	Recommended for use
AAFP1	31	11	17	64	2	46	17	No
PSGS	61	39	42	61	27	50	50	No
DAS	83	58	67	81	44	46	75	Yes
S3	78	72	65	67	54	79	75	Yes
BSG	69	56	60	64	25	25	58	Yes, with modifications
SAGES	56	36	59	67	33	50	50	Yes, with modifications
ASGE1	50	36	35	64	27	29	42	No 
EAES	78	36	68	69	29	46	58	Yes, with modifications
ASGE2	50	44	38	56	28	50	56	Yes, with modifications
EAES/ISS	72	64	73	75	56	42	75	Yes
AAFP2	25	36	27	58	25	50	25	No
NICE	44	61	61	58	69	54	75	Yes
UMH	56	56	49	64	40	58	67	Yes, with modifications
EASL	81	61	70	83	54	63	75	Yes
Mean scores (SD)	59.6 (18.4)	47.6 (16.3)	52.2 (17.7)	66.5 (8.2)	36.6 (17.3)	49.1 (13.2)	57.0 (19.0)	 
Maximum score per domain is 100 (%). The scores are the scaled domain scores of the two reviewers. 
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